Victory Capital Management Inc Relay Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 73,886 shares of RLAY stock, worth $307,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,886

Previous 76,539 3.47%

Holding current value

$307,365

Previous $499,000 4.81%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$6.23 - $9.51 $16,528 - $25,230	-2,653 Reduced 3.47%	73,886 $523,000
Q2 2024 Aug 05, 2024	BUY	$5.9 - $8.02 $45,312 - $61,593	7,680 Added 11.15%	76,539 $499,000
Q1 2024 May 03, 2024	BUY	$7.5 - $12.07 $430,440 - $692,721	57,392 Added 500.5%	68,859 $571,000
Q4 2023 Feb 05, 2024	BUY	$6.01 - $11.48 $68,916 - $131,641	11,467 New	11,467 $126,000
Q4 2022 Feb 10, 2023	SELL	$14.16 - $24.02 $134,760 - $228,598	-9,517 Reduced 17.28%	45,560 $680,000
Q4 2022 Feb 09, 2023	SELL	$14.16 - $24.02 $170,670 - $289,513	-12,053 Reduced 17.95%	55,077 $822,000
Q3 2022 Nov 02, 2022	SELL	$18.07 - $31.37 $29,996 - $52,074	-1,660 Reduced 2.41%	67,130 $1.5 Million
Q2 2022 Aug 01, 2022	BUY	$13.31 - $34.88 $793,276 - $2.08 Million	59,600 Added 648.53%	68,790 $1.15 Million
Q1 2022 May 04, 2022	SELL	$20.26 - $32.36 $11,264 - $17,992	-556 Reduced 5.7%	9,190 $219,000
Q4 2021 Feb 07, 2022	BUY	$26.0 - $37.03 $36,478 - $51,953	1,403 Added 16.82%	9,746 $299,000
Q3 2021 Nov 02, 2021	SELL	$29.75 - $37.99 $23,086 - $29,480	-776 Reduced 8.51%	8,343 $263,000
Q2 2021 Aug 03, 2021	BUY	$27.5 - $38.19 $53,762 - $74,661	1,955 Added 27.29%	9,119 $334,000
Q1 2021 May 04, 2021	SELL	$32.52 - $61.53 $28,552 - $54,023	-878 Reduced 10.92%	7,164 $248,000
Q4 2020 Feb 01, 2021	BUY	$35.51 - $54.03 $285,571 - $434,509	8,042 New	8,042 $334,000

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Relay Therapeutics, Inc. Transaction History